Exact Mass: 402.1807
Exact Mass Matches: 402.1807
Found 263 metabolites which its exact mass value is equals to given mass value 402.1807
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Methyl 7-epi-12-hydroxyjasmonate glucoside
Methyl 7-epi-12-hydroxyjasmonate glucoside is found in potato. Methyl 7-epi-12-hydroxyjasmonate glucoside is isolated from potato leaves (Solanum tuberosum) and Jerusalen artichoke (Helianthus tuberosus Isolated from potato leaves (Solanum tuberosum) and Jerusalen artichoke (Helianthus tuberosus). Methyl 7-epi-12-hydroxyjasmonate glucoside is found in root vegetables and potato.
D-Linalool 3-(6'-malonylglucoside)
D-Linalool 3-(6-malonylglucoside) is found in herbs and spices. D-Linalool 3-(6-malonylglucoside) is a constituent of Arabian jasmine (Jasminum sambac) buds. Constituent of Arabian jasmine (Jasminum sambac) buds. D-Linalool 3-(6-malonylglucoside) is found in herbs and spices.
Clocinizine
Clocinizine is a first-generation diphenylmethylpiperazine H1-antihistamine. C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
Dibenzo-P-dioxin
1,2-Pentanediol, 5-(6-bromodecahydro-2-hydroxy-2,5,5a,8a-tetramethyl-1-naphthalenyl)-3-methylene-
AVE5638
CONFIDENCE standard compound; INTERNAL_ID 479; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8392; ORIGINAL_PRECURSOR_SCAN_NO 8390 CONFIDENCE standard compound; INTERNAL_ID 479; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8421; ORIGINAL_PRECURSOR_SCAN_NO 8418 CONFIDENCE standard compound; INTERNAL_ID 479; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8427; ORIGINAL_PRECURSOR_SCAN_NO 8425 CONFIDENCE standard compound; INTERNAL_ID 479; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8465; ORIGINAL_PRECURSOR_SCAN_NO 8463 CONFIDENCE standard compound; INTERNAL_ID 479; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8474; ORIGINAL_PRECURSOR_SCAN_NO 8472 CONFIDENCE standard compound; INTERNAL_ID 479; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8478; ORIGINAL_PRECURSOR_SCAN_NO 8477
laurendecumtriol|rel-(1R,2R,3R,6R)-3-bromo-alpha-ethenyl-6-hydroxy-2-[(2E)-4-hydroxy-4-methylpent-2-en-1-yl]-alpha,2,6-trimethylcyclohexanepropanol
(1R,6R,9R)-6,9,11-trihydroxy-4,7-megastigmadien-3-one 11-O-beta-D-glucopyranoside
3beta-hydroxy-5alpha,6alpha-epoxy-beta-ionone-2alpha-Obeta-D-glucopyranoside
3alpha-(2-hydroxy-2-methyl-3-chloro-butyryloxy)-4alpha,11-dihydroxy-6,7-dehydroeudesman-8-one
(6S,7E,9S)-6,9,10-trihydroxy-4,7-megastigmadien-3-one 10-O-beta-D-glucopyranoside|(6S,7E,9xi)-6,9,10-trihydroxy-4,7-megastigmadien-3-one 10-O-beta-D-glucopyranoside|cucumegastigmane II|parvispinoside C
(1S,3S,5R,6R)-megastigman-3-ol-9-on-12(5)-olide beta-D-glucopyranoside|everlastoside A|supinaionoside A
(6S,7E,9S)-6,9,10-trihydroxy-4,7-megastigmadien-3-one 9-O-beta-D-glucopyranoside
(1R,2R)-2-[(2Z)-6-(beta-D-glucopyranosyloxy)-2-hexenyl]-3-oxocyclopentaneacetic acid
(2R,6S,9S,7E)-trihydroxymegastigmane-4,7-dien-3-one 9-O-beta-glucopyranoside|sauroposide
C19H30O9_2-Cyclohexen-1-one, 4-[(1E)-3-(beta-D-glucopyranosyloxy)-1-buten-1-yl]-4-hydroxy-5-(hydroxymethyl)-3,5-dimethyl
C19H30O9_1-Cyclohexene-1-carboxylic acid, 6-[3-(beta-D-glucopyranosyloxy)butyl]-5,5-dimethyl-3-oxo
C19H30O9_(3E)-4-(8-Hydroxy-1,5-dimethyl-3-oxo-6-oxabicyclo[3.2.1]oct-8-yl)-3-buten-2-yl beta-D-glucopyranoside
Ala Ala Asn Gln
Ala Ala Gln Asn
Ala Asp Pro Thr
Ala Asp Thr Pro
Ala Glu Pro Ser
Ala Glu Ser Pro
Ala Gly Gln Gln
Ala Asn Ala Gln
Ala Asn Gln Ala
Ala Pro Asp Thr
Ala Pro Glu Ser
Ala Pro Ser Glu
Ala Pro Thr Asp
Ala Gln Ala Asn
Ala Gln Gly Gln
Ala Gln Asn Ala
Ala Gln Gln Gly
Ala Ser Glu Pro
Ala Ser Pro Glu
Ala Thr Asp Pro
Ala Thr Pro Asp
Asp Ala Pro Thr
Asp Ala Thr Pro
Asp Pro Ala Thr
Asp Pro Thr Ala
Asp Thr Ala Pro
Asp Thr Pro Ala
Glu Ala Pro Ser
Glu Ala Ser Pro
Glu Gly Pro Thr
Glu Gly Thr Pro
Glu Pro Ala Ser
Glu Pro Gly Thr
Glu Pro Ser Ala
Glu Pro Thr Gly
Glu Ser Ala Pro
Glu Ser Pro Ala
Glu Thr Gly Pro
Glu Thr Pro Gly
Gly Ala Gln Gln
Gly Glu Pro Thr
Gly Glu Thr Pro
Gly Asn Asn Val
Gly Asn Val Asn
Gly Pro Glu Thr
Gly Pro Thr Glu
Gly Gln Ala Gln
Gly Gln Gln Ala
Gly Thr Glu Pro
Gly Thr Pro Glu
Gly Val Asn Asn
Asn Ala Ala Gln
Asn Ala Gln Ala
Asn Gly Asn Val
Asn Gly Val Asn
Asn Asn Gly Val
Asn Asn Val Gly
Asn Gln Ala Ala
Asn Val Gly Asn
Asn Val Asn Gly
Pro Ala Asp Thr
Pro Ala Glu Ser
Pro Ala Ser Glu
Pro Ala Thr Asp
Pro Asp Ala Thr
Pro Asp Thr Ala
Pro Glu Ala Ser
Pro Glu Gly Thr
Pro Glu Ser Ala
Pro Glu Thr Gly
Pro Gly Glu Thr
Pro Gly Thr Glu
Pro Ser Ala Glu
Pro Ser Glu Ala
Pro Thr Ala Asp
Pro Thr Asp Ala
Pro Thr Glu Gly
Pro Thr Gly Glu
Gln Ala Ala Asn
Gln Ala Gly Gln
Gln Ala Asn Ala
Gln Ala Gln Gly
Gln Gly Ala Gln
Gln Gly Gln Ala
Gln Asn Ala Ala
Gln Gln Ala Gly
Gln Gln Gly Ala
Ser Ala Glu Pro
Ser Ala Pro Glu
Ser Glu Ala Pro
Ser Glu Pro Ala
Ser Pro Ala Glu
Ser Pro Glu Ala
Thr Ala Asp Pro
Thr Ala Pro Asp
Thr Asp Ala Pro
Thr Asp Pro Ala
Thr Glu Gly Pro
Thr Glu Pro Gly
Thr Gly Glu Pro
Thr Gly Pro Glu
Thr Pro Ala Asp
Thr Pro Asp Ala
Thr Pro Glu Gly
Thr Pro Gly Glu
Val Gly Asn Asn
Val Asn Gly Asn
Val Asn Asn Gly
Methyl 7-epi-12-hydroxyjasmonate glucoside
D-Linalool 3-(6''-malonylglucoside)
Lorajmine
C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii > C01BA - Antiarrhythmics, class ia C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents
l-n-valyl-l-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid benzyl ester hcl
[2-[(8S,9R,10S,11S,13S,14S)-9-fluoro-11-hydroxy-10,13-dimethyl-3-oxo-7,8,11,12,14,15-hexahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate
TERT-BUTYL 4-(2-METHYL-6-((5-VINYLTHIAZOL-2-YL)AMINO)PYRIMIDIN-4-YL)PIPERAZINE-1-CARBOXYLATE
Ombrabulin
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent
L-N-VALYL-L-1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBOXYLIC ACID BENZYL ESTER HYDROCHLORIDE
SKF-96365
D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid bis(1-methylethyl) ester
1-(alpha-(2-piperidinioethoxycarbonyl)benzyl)piperidinium dichloride
Turisteron
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
8-hydroxy-1,5-dimethyl-8-[(E)-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybut-1-enyl]-6-oxabicyclo[3.2.1]octan-3-one
D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids
1-{3-[1-({5-[(2-Fluorophenyl)ethynyl]furan-2-yl}carbonyl)piperidin-4-yl]phenyl}methanamine
2-amino-3-hydroxy-N-[2-methoxy-5-[(E)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl]propanamide
1-[3-[4-(2-Fluorophenyl)-1-piperazinyl]propyl]-3-[4-(methylthio)phenyl]urea
4-hydroxy-5-(hydroxymethyl)-3,5-dimethyl-4-[(E)-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybut-1-enyl]cyclohex-2-en-1-one
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-(2-oxo-2-piperidin-1-ylethyl)-3,6-dihydro-2H-pyran-3-yl]-1,3-benzodioxole-5-carboxamide
N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-1,3-benzodioxole-5-carboxamide
N-[(2S,3S,6R)-2-(hydroxymethyl)-6-(2-oxo-2-piperidin-1-ylethyl)-3,6-dihydro-2H-pyran-3-yl]-1,3-benzodioxole-5-carboxamide
N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-1,3-benzodioxole-5-carboxamide
N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-1,3-benzodioxole-5-carboxamide
N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-1,3-benzodioxole-5-carboxamide
N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-1,3-benzodioxole-5-carboxamide
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-1,3-benzodioxole-5-carboxamide
(4-fluorophenyl)-[(1S,5R)-7-[4-(4-methoxyphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]methanone
[(3aS,4S,9bS)-4-(hydroxymethyl)-8-phenyl-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(3-fluorophenyl)methanone
3-Oxo-5,5-dimethyl-6-[3-(beta-D-glucopyranosyloxy)butyl]-1-cyclohexene-1-carboxylic acid
(2-hydroxy-3-phosphonooxypropyl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
SSR411298
SSR411298 is an orally active, selective and reversible fatty acid amide hydrolase (FAAH) inhibitor. SSR411298 has the potential for post-traumatic stress disorder research[1].
(1s,2s,3s,4s)-4-bromo-2-[(3s)-3-hydroxy-3-methylpent-4-en-1-yl]-3-[(2e)-4-hydroxy-4-methylpent-2-en-1-yl]-1,3-dimethylcyclohexan-1-ol
4-hydroxy-4-(3-hydroxybut-1-en-1-yl)-5,5-dimethyl-3-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)cyclohex-2-en-1-one
4-(4-hydroxy-2,2,6-trimethyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-7-oxabicyclo[4.1.0]heptan-1-yl)but-3-en-2-one
methyl 2-[(1r,2r)-3-oxo-2-[(2z)-5-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pent-2-en-1-yl]cyclopentyl]acetate
(3e)-4-[(1r,4s,5s,6s)-5-hydroxy-2,2,6-trimethyl-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-7-oxabicyclo[4.1.0]heptan-1-yl]but-3-en-2-one
1-hydroxy-7-(2-hydroxypropan-2-yl)-1,4a-dimethyl-6-oxo-3,4,5,8a-tetrahydro-2h-naphthalen-2-yl 3-chloro-2-hydroxy-2-methylbutanoate
5,5-dimethyl-3-oxo-6-(3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butyl)cyclohex-1-ene-1-carboxylic acid
(1s,2s,4ar,8ar)-1-hydroxy-7-(2-hydroxypropan-2-yl)-1,4a-dimethyl-6-oxo-3,4,5,8a-tetrahydro-2h-naphthalen-2-yl (2r,3s)-3-chloro-2-hydroxy-2-methylbutanoate
methyl 2-[(1r,2r)-3-oxo-2-[(2z)-5-{[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pent-2-en-1-yl]cyclopentyl]acetate
(1r,2r)-methyl-5'-hydroxyjasmonate 5'-o-β-d-glucopyranoside
{"Ingredient_id": "HBIN003068","Ingredient_name": "(1r,2r)-methyl-5'-hydroxyjasmonate 5'-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C19H30O9","Ingredient_Smile": "COC(=O)CC1CCC(=O)C1CC=CCCOC2C(C(C(C(O2)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14502","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(1r,6r,9s)-6,9,11-trihydroxy-4,7-megastigma-dien-3-one 11-o-β-d-glucopyranoside
{"Ingredient_id": "HBIN003164","Ingredient_name": "(1r,6r,9s)-6,9,11-trihydroxy-4,7-megastigma-dien-3-one 11-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C19H30O9","Ingredient_Smile": "CC(=O)C=CC12C(C(C(CC1(O2)C)O)OC3C(C(C(C(O3)CO)O)O)O)(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21749","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6-hydroxy-junipeionoloside
{"Ingredient_id": "HBIN012440","Ingredient_name": "6-hydroxy-junipeionoloside","Alias": "NA","Ingredient_formula": "C19H30O9","Ingredient_Smile": "CC1=CC(=O)CC(C1(C=CC(C)O)O)(C)COC2C(C(C(C(O2)CO)O)O)O","Ingredient_weight": "402.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10270","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "100966498","DrugBank_id": "NA"}
ampelopsisrhamnoside
{"Ingredient_id": "HBIN015901","Ingredient_name": "ampelopsisrhamnoside","Alias": "NA","Ingredient_formula": "C19H30O9","Ingredient_Smile": "CC1C(C(C(C(O1)OC2=CC(=C(C=C2)OC(CO)CO)C(=O)C)O)O)O","Ingredient_weight": "402.44","OB_score": "NA","CAS_id": "138614-65-0","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "6824","PubChem_id": "101608827","DrugBank_id": "NA"}
apocynoside ii
{"Ingredient_id": "HBIN016509","Ingredient_name": "apocynoside ii","Alias": "NA","Ingredient_formula": "C19H30O9","Ingredient_Smile": "CC(C=CC1(C(=CC(=O)CC1(C)C)COC2C(C(C(C(O2)CO)O)O)O)O)O","Ingredient_weight": "402.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1530","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11025815","DrugBank_id": "NA"}
austroside a
{"Ingredient_id": "HBIN017384","Ingredient_name": "austroside a","Alias": "NA","Ingredient_formula": "C19H30O9","Ingredient_Smile": "CC1CC(=O)CC(C1(C=CC(=O)COC2C(C(C(C(O2)CO)O)O)O)O)(C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2022","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}